1
Ceftolozane-tazobactam Versus Meropenem for ESBL and AmpC-producing Enterobacterales Bloodstream Infection
Condition(s):Bacteremia Caused by Gram-Negative BacteriaLast Updated:January 23, 2020Not yet recruiting
Ceftolozane, Tazobactam Drug Combination as an Intervention: 21 Clinical Trials, Page 1 of 3
Hide Studies Not Open or Pending
2
Clinical Outcomes With Ceftolozane-tazobactam for MDR Pseudomonas Infections
Condition(s):Pseudomonas Infections; Pseudomonas AeruginosaLast Updated:April 27, 2018Unknown status
3
Ceftolozane-Tazobactam for Directed Treatment of Pseudomonas Aeruginosa Bacteremia and Pneumonia in Patients With Hematological Malignancies and Hematopoietic Stem Cell Transplantation
Condition(s):Pseudomonas Aeruginosa; Pneumonia; Hematologic MalignancyLast Updated:December 17, 2020Recruiting
4
Short Infusion Versus Prolonged Infusion of Ceftolozane-tazobactam Among Patients With Ventilator Associated-pneumonia
Condition(s):Ventilator-associated PneumoniaLast Updated:April 8, 2020Recruiting
5
Monitoring of Ceftolozane-Tazobactam Plasmatic Levels in Critical Patients
Condition(s):Serious InfectionLast Updated:February 6, 2020Not yet recruiting
6
Ceftolozane-tazobactam for the Treatment of Respiratory Infections Due to Extensively Drug-resistant Pseudomonas Aeruginosa Among Critically Ill Patients: a Retrospective Study.
Condition(s):Ventilator Associated Pneumonia; Antibiotic Resistant InfectionLast Updated:April 20, 2020Active, not recruiting
7
Pharmacokinetics of Ceftolozane/Tazobactam in Plasma and Cerebrospinal Fluid
Condition(s):PharmacokineticsLast Updated:September 10, 2020Completed
8
Comparative Study To Determine The Efficacy, Safety, And Tolerability Of Ceftolozane-Tazobactam
Condition(s):Other Infectious DiseasesLast Updated:October 22, 2020Recruiting
9
An Observational Pharmacokinetic Sudy of Ceftolozane-Tazobactam in Intensive Care Unit in Patients With and Without CRRT
Condition(s):Gram-Negative Bacterial InfectionsLast Updated:October 2, 2019Completed
10
In Vitro Activity of Ceftolozane-tazobactam Against Contemporary Nosocomial Gram “-” Pathogens Isolated in Russia
Condition(s):Nosocomial InfectionLast Updated:December 22, 2020Completed